GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InVivo Therapeutics Holdings Corp (OTCPK:NVIVQ) » Definitions » Shiller PE Ratio

InVivo Therapeutics Holdings (InVivo Therapeutics Holdings) Shiller PE Ratio : (As of May. 03, 2024)


View and export this data going back to 2010. Start your Free Trial

What is InVivo Therapeutics Holdings Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


InVivo Therapeutics Holdings Shiller PE Ratio Historical Data

The historical data trend for InVivo Therapeutics Holdings's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InVivo Therapeutics Holdings Shiller PE Ratio Chart

InVivo Therapeutics Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

InVivo Therapeutics Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of InVivo Therapeutics Holdings's Shiller PE Ratio

For the Biotechnology subindustry, InVivo Therapeutics Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InVivo Therapeutics Holdings's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InVivo Therapeutics Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where InVivo Therapeutics Holdings's Shiller PE Ratio falls into.



InVivo Therapeutics Holdings Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

InVivo Therapeutics Holdings's E10 for the quarter that ended in Sep. 2023 is calculated as:

For example, InVivo Therapeutics Holdings's adjusted earnings per share data for the three months ended in Sep. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.87/129.8595*129.8595
=-0.870

Current CPI (Sep. 2023) = 129.8595.

InVivo Therapeutics Holdings Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201312 -5,436.190 98.326 -7,179.603
201403 -4,846.150 99.695 -6,312.471
201406 -3,187.530 100.560 -4,116.280
201409 -937.509 100.428 -1,212.258
201412 -6,937.570 99.070 -9,093.692
201503 -12,000.100 99.621 -15,642.539
201506 -7,312.570 100.684 -9,431.564
201509 -1,687.520 100.392 -2,182.859
201512 -3,187.530 99.792 -4,147.922
201603 -4,500.040 100.470 -5,816.369
201606 -3,000.030 101.688 -3,831.150
201609 -3,562.540 101.861 -4,541.774
201612 -3,187.530 101.863 -4,063.618
201703 -3,735.040 102.862 -4,715.342
201706 -3,690.040 103.349 -4,636.584
201709 -5,242.550 104.136 -6,537.581
201712 -2,482.520 104.011 -3,099.465
201803 -2,505.030 105.290 -3,089.595
201806 -5,610.060 106.317 -6,852.347
201809 -315.003 106.507 -384.071
201812 -203.432 105.998 -249.227
201903 -212.250 107.251 -256.993
201906 -253.250 108.070 -304.313
201909 -215.750 108.329 -258.630
201912 -200.750 108.420 -240.447
202003 -61.750 108.902 -73.634
202006 -12.250 108.767 -14.626
202009 -11.750 109.815 -13.895
202012 -2.319 109.897 -2.740
202103 -1.890 111.754 -2.196
202106 -1.680 114.631 -1.903
202109 -1.790 115.734 -2.008
202112 -2.010 117.630 -2.219
202203 -1.940 121.301 -2.077
202206 -1.970 125.017 -2.046
202209 -1.980 125.227 -2.053
202212 -0.950 125.222 -0.985
202303 -0.850 127.348 -0.867
202306 -0.620 128.729 -0.625
202309 -0.870 129.860 -0.870

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


InVivo Therapeutics Holdings  (OTCPK:NVIVQ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


InVivo Therapeutics Holdings Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of InVivo Therapeutics Holdings's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


InVivo Therapeutics Holdings (InVivo Therapeutics Holdings) Business Description

Traded in Other Exchanges
Address
One Kendall Square, Suite B14402, Building 1400 West, 4th Floor, Cambridge, MA, USA, 02139
InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.
Executives
Brice Foose 10 percent owner 236 SILENT MEADOW DRIVE, LAKE ST. LOUIS MO 63367
Daniel R Marshak director C/O CAMBREX CORP, ONE MEADOWLANDS PLZ, EAST RUTHERFORD NJ 07073
Christina Morrison director ARAMARK, 1101 MARKET STREET, PHILADELPHIA PA 19107
Richard M. Toselli director, officer: CEO and CMO C/O INVIVO THERAPEUTICS HOLDINGS CORP., 1 KENDALL SQUARE, SUITE B14402, CAMBRIDGE MA 02139
Richard Christopher officer: Chief Financial Officer C/O LUCID, INC., 50 METHODIST HILL DR, SUITE 1000, ROCHESTER NY 14623
C Ann Merrifield director
Bob Rosenthal director 20 NEWBURY ST, BOSTON MA 02116
Heather Hamel officer: Chief Legal Officer and GC ONE KENDALL SQUARE, BUILDING 1400 WEST, FLOOR 4, CAMBRIDGE MA 02139
Jeffrey Modestino officer: See Remarks C/O INVIVO THERAPEUTICS HOLDINGS CORP., 1 KENDALL SQUARE, SUITE B14403, CAMBRIDGE MA 02139
Christopher Mcnulty officer: Chief Financial Officer C/O INVIVO THERAPEUTICS HOLDINGS CORP., 1 KENDALL SQUARE, SUITE B14402, CAMBRIDGE MA 02139
Melanie Golarz officer: Interim CFO C/O INVIVO THERAPEUTICS HOLDINGS CORP., 1 KENDALL SQUARE, SUITE B14402, CAMBRIDGE MA 02139
Jeffrey S. Hatfield director 11080 ROSELLE STREET, SAN DIEGO CA 92121
Pamela J Stahl officer: Chief Commercial Officer ONE KENDALL SQUARE, SUITE B14402, CAMBRIDGE MA 02139
Richard John Roberts director ONE BROADWAY, 14TH FLOOR, CAMBRIDGE MA 02142
Masuoka K. Lorianne officer: Chief Medical Officer C/O NEKTAR THERAPEUTICS, 201 INDUSTRIAL ROAD, SAN CARLOS CA 94070

InVivo Therapeutics Holdings (InVivo Therapeutics Holdings) Headlines